Related Experiment Video
Updated: Jan 24, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
An integrated approach to processing WHO-2016 verbal autopsy data: the InterVA-5 model
Peter Byass1,2,3,4, Laith Hussain-Alkhateeb5, Lucia D'Ambruoso6,7,8
1Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden. peter.byass@umu.se.
The InterVA-5 model accurately assigns causes of death from verbal autopsy data, harmonizing various international standards for global health planning. This tool improves cause-specific mortality measurement worldwide.
Area of Science:
- Public Health
- Biostatistics
- Epidemiology
Background:
- Verbal autopsy (VA) is crucial for determining causes of uncertified deaths, addressing significant global mortality uncertainty.
- The World Health Organization (WHO) provides international standards for VA interviews and cause categories.
- Computer models are essential for efficiently processing VA data and standardizing cause assignment.
Purpose of the Study:
- To introduce the InterVA-5 model, designed to align with the WHO-2016 verbal autopsy standard.
- To create a harmonizing model capable of processing data from WHO-2016, WHO-2012, and Tariff-2 formats.
- To generate standardized cause-specific mortality profiles for diverse populations.
Main Methods:
- Developed InterVA-5 building upon the InterVA-4 model.
- Utilized a training dataset from the Population Health Metrics Research Collaboration (PHMRC) and expert input for the knowledge base.
- Evaluated the model using test datasets from PHMRC and the Afghanistan National Mortality Survey.
Main Results:
- InterVA-5 demonstrated high concordance with hospital-assigned causes (CCC 0.92 for children, 0.86 for adults).
- The model showed excellent performance in harmonizing different input formats (CCC up to 0.97 for WHO-2016/WHO-2012).
- Evaluated datasets included approximately 75% of input items from WHO-2016, WHO-2012, and Tariff-2 formats.
Conclusions:
- InterVA-5 performs well and effectively harmonizes various input formats for cause-of-death assignment.
- The model is a valuable resource for global cause-specific mortality measurement and evaluation.
- Future re-versioning of InterVA-5 is anticipated as more WHO-2016 data becomes available.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Physiological Models
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Information Processing Approach
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...

